Insider Trading November 21, 2026 11:16 AM

Oxford Square Capital CEO Cohen Boosts Stake with $24,598 Share Purchase

The buy comes as the stock trades at $0.60, down 17% over the past week, and offers a 30% dividend yield.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
OXSQ

Oxford Square Capital Corp. (NASDAQ:OXSQ) CEO Jonathan H. Cohen purchased $24,598 of company stock on November 18 and 19, 2026, at prices between $0.5448 and $0.55 per share. The transactions were executed in a joint account with President and COO Saul B. Rosenthal, with Cohen holding a 50% pecuniary interest. Following the purchases, Cohen directly owns 2,462,137 shares and indirectly owns 2,169.448 shares through Oxford Funds, LLC. The buying occurred as OXSQ trades at $0.60, down 17% over the past week, though analysis suggests the company is undervalued. The stock offers a 30% dividend yield, and the company has maintained dividend payments for 23 consecutive years. In other news, Oxford Square reported mixed Q3 2026 results, with net investment income of $4.9 million, or $0.04 per share, missing estimates, while total investment income rose to $9.9 million and net asset value per share decreased to $1.21 from $1.29.

Oxford Square Capital CEO Cohen Boosts Stake with $24,598 Share Purchase
OXSQ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Jonathan H. Cohen bought $24,598 of OXSQ stock on November 18-19, 2026, at prices between $0.5448 and $0.55 per share, increasing his direct holdings to 2,462,137 shares.
  • The purchases occurred as OXSQ trades at $0.60, down 17% over the past week, with a 30% dividend yield and a 23-year history of dividend payments.
  • Oxford Square reported mixed Q3 2026 results: net investment income of $4.9 million ($0.04 per share) missed estimates, while total investment income rose to $9.9 million and NAV per share fell to $1.21 from $1.29.

Oxford Square Capital Corp. (NASDAQ:OXSQ) disclosed that its Chief Executive Officer and Director, Jonathan H. Cohen, acquired shares of the company’s common stock totaling $24,598 across two transactions on November 18 and 19, 2026. The shares were purchased at prices ranging from $0.5448 to $0.55, according to the filing.

The insider buying comes as the stock trades at $0.60, down 17% over the past week. Despite the recent decline, an analysis suggests the company is undervalued at current levels. The stock offers an attractive 30% dividend yield, and the company has maintained dividend payments for 23 consecutive years.

On November 19, Mr. Cohen purchased 21,678 shares, with prices for these transactions ranging from $0.5498 to $0.55 per share. The previous day, November 18, he acquired an additional 23,266 shares, with prices ranging from $0.5165 to $0.55 per share. These shares were purchased into a joint tenants in common account, with the reported numbers reflecting Mr. Cohen’s 50% pecuniary interest in the account. Saul B. Rosenthal, President and Chief Operating Officer of Oxford Square Capital Corp., holds the other 50% pecuniary interest in this account.

Following these transactions, Mr. Cohen directly beneficially owns 2,462,137 shares of Oxford Square Capital Corp. common stock. Additionally, he indirectly beneficially owns 2,169.448 shares held by Oxford Funds, LLC, by virtue of his ownership interest in the entity.

In other recent news, Oxford Square Capital Corp reported mixed results for the third quarter of 2026. The company’s net investment income was $4.9 million, or $0.04 per share, falling short of analysts’ expectations of $0.05 per share. However, total investment income increased to $9.9 million, up from $9.4 million in the previous quarter. Despite this rise, the net asset value per share decreased to $1.21 from $1.29. These developments come as investors assess the impact of softer earnings against the backdrop of lower leverage and a reduced dividend. Additionally, there were no significant upgrades or downgrades from analysts following the earnings release. The focus remains on how Oxford Square Capital will navigate its financial strategy moving forward.

These updates provide a snapshot of the company’s recent performance and market position.

Risks

  • The stock’s 17% decline over the past week and the recent NAV decrease to $1.21 from $1.29 highlight potential valuation and performance concerns.
  • The company’s net investment income fell short of analyst expectations, and the reduced dividend and lower leverage may signal challenges in sustaining earnings.
  • Insider buying activity is reported with a 50% pecuniary interest due to the joint account with the COO, which may limit the signal’s strength.

More from Insider Trading

Comstock Director Leo Drozdoff Adds 15,000 Shares Near 52-Week Low Nov 21, 2026 Vivos Inc President Brad Weeks Purchases $5,790 in Company Stock Nov 21, 2026 Bank of America Reports Matching Buy and Sell of Nuveen Minnesota Fund Shares Nov 21, 2026 Medifast Director Parsa Kiai Discloses $1.13 Million Stock Purchase Nov 21, 2026 York Water Director Brossman Adds 31.971 Shares in Small Open-Market Purchase Nov 21, 2026